TP53 and triple-negative breast carcinoma: Therefore, we tested two cell lines with mutation in p53, the triple-negative breast cancer cell line, MDA-MB-231, and the pancreatic cancer cell line, MIA PaCa-2, with Arg280 and Arg248 mutation respectively to see whether loss of IKKβ affects the activation of mutp53.